About Daniel LaBarbera
Form D filings for Onconaut Therapeutics in 2024 list Daniel LaBarbera as chief executive officer and director.
Daniel LaBarbera first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel LaBarbera in the role, so the role may have started earlier or lasted longer.